期刊文献+

2型糖尿病肾病与血浆抵抗素及胰岛素抵抗的关系 被引量:2

Relationship between Type 2 Diabetic Nephropathy and Plasma Resistin and Insulin Resistance
原文传递
导出
摘要 目的探讨血浆抵抗素及胰岛素抵抗与2型糖尿病肾病(DN)之间的相互关系。方法选取60例临床确诊的2型糖尿病患者,按有无DN分为2组:DN组30例和无DN组30例,以30例同期体检的健康志愿者作为对照组。采用双抗体夹心酶联免疫吸附试验测定所选90例实验对象的血浆抵抗素浓度,时间分辨分析法测定胰岛素,氧化酶法测定血糖,全自动生化分析仪检测血脂。结果①DN组血浆抵抗素浓度高于无DN组及对照组(P<0.05),差异有统计学意义;②60例病例相关分析得出:血浆抵抗素浓度与空腹胰岛素(FINS)、糖化血红蛋白(HbAlc)、胰岛素抵抗指数(HOMA-IR)、胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)呈正相关,与空腹血糖(FPG)、甘油三酯(TG)、体重指数(BMI)、高密度酯蛋白胆固醇(HDL-C)均无相关性。结论空腹血浆抵抗素水平在2型糖尿病有DN者中显著升高,并与2型糖尿病患者血糖控制不良的程度有关、与2型糖尿病脂代谢紊乱相关,在2型DN的发生、发展中可能起一定作用。 [ Objective] To discuss the relationship between plasma resistin and insulin resistance with type 2 diabetic nephropathy ( DN ). [ Methods ] Totally 60 cases of type 2 diabetes were selected, and divided into 2 groups according to whether they had DN or not: 30 cases of DN group, 30 cases of non-DN group, 30 cases of healthy volunteers as control group. Double-antibody sandwich enzyme-linked immunosorbent assay was adopted to determine the plasma resistin concentration of 90 selected subjects , time-resolved method was for determination of insulin; blood glucose was determined by oxidase method; lipids was determined by automatic biochemical analyzer. [ Results] (1)Plasma resistin concentration of DN group was higher than that of non-DN group ( P 〈 0. 05 ), the difference was significant; (2)Case Correlation analysis on 60 cases showed that there was a significant positive correlation between plasma resistin concentration and FINS, HbA1c, HOMA-IR, TC, LDL-C, and no correlation between plasma resistin concentration and FBG, TG, BMI, HDL-C. [ Conclusion ] Fasting plasma resistin level is significantly high in patient with type 2 diabetes and DN, and relates with poor control of blood glucose and lipid metabolic disorders, and may play a role in the occurrence and development of DN in patient with type 2 diabetes.
作者 赵丽岩
出处 《职业与健康》 CAS 2010年第2期227-228,共2页 Occupation and Health
基金 河北省科学技术研究与发展计划项目(编号09276101D-6)
关键词 2型糖尿病 抵抗素 糖尿病肾病 Type 2 diabetes mellitus Resistin diabetic nephropathy
  • 相关文献

参考文献7

  • 1De Jager J,Dekker JM, Kooy A, et al Endothelial dysfunction and lowgrade inflammation explainmuch of the excess cardiovascularmortalityin Individuals with type 2 diabetes:the Hoom study. Arterioscler Thromb VascBio, 12006,26 : 1086 - 1093.
  • 2向光大.胰岛素抵抗与血管内皮功能[J].中华糖尿病杂志(1006-6187),2005,13(5):321-323. 被引量:21
  • 3李志臻,黎锋,严励,李芳萍,李焱,程桦,傅祖植.抵抗素诱导脐静脉内皮细胞功能异常[J].中山大学学报(医学科学版),2006,27(3):258-261. 被引量:12
  • 4Osawa H, Ochi M, Kato K, et al Serum resistin is associatedwith the severity of microangiopathies in type 2 diabetes. Biochem Biophys Res Commun ,2007,355:342 - 346.
  • 5Axelsson J, Bergsten A, Qureshi AR, et al Elevated resistin levels inchronic kidney disease are associated with decreased glomerular filtration rate and inflammation, bumotwith insulin resistance. Kidney lnt, 2006, 69:596-604.
  • 6汤玮,刘志民.糖尿病微血管病相关蛋白的研究进展[J].中华内分泌代谢杂志,2007,23(2):189-192. 被引量:11
  • 7Deepa R, Mohan A, Rema M, et al Lipoprotein(a) in south Indian type2 diabetic subjects in relation to diabetic vascular complications. Assoc Physicians India, 2002,50:657 - 661.

二级参考文献47

  • 1赵晓娟,于学满.不同糖耐量状态下血清抵抗素和可溶性细胞间黏附分子质量浓度的变化[J].中国实用内科杂志,2005,25(6):510-511. 被引量:6
  • 2KOUGIAS P,CHAI H,LIN P H,et al.Adipocytederived cytokine resistin causes endothelial dysfunction of porcine coronary arteries[J].J Vasc Surg,2005,41(4):691-698.
  • 3COOKE J P,OKA P K,Does leptin cause vascular disease[J].Circulation,2002,106(15):1904-1905.
  • 4STEPPAN C M,BAILEY S T,BHAT S,et al.The hormone resistin links obesity to diabetes[J].Nature,2001,409(6818):307-312.
  • 5BANERJEE R R,RANGWALA S M,SHAPIRO J S,et al.Regulation of fasted blood glucose by resistin[J].Science,2004,303(5661):1195-1198.
  • 6RANGWALA S M,RICH A S,RHOADES B,et al.Abnormal glucose homeostasis due to chronic hyperresistinemia[J].Diabetes,2004,53(8):1937-1941.
  • 7FEHMANN H C,HEYN J.Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls[J].Horm Metab Res,2002,34(11-12):671-673.
  • 8KAWANAMI D,MAEMURA K,TAKEDA N,et al.Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells:a new insight into adipocytokine-endithelial cell interactions[J].Biochem Biophys Res Commun,2004,314(2):415-419.
  • 9VERMA S,LIS H,WANG C H,et al.Resistin promotes endothelial cell activation:further evidence of adipokine-endothelial interaction[J].Circulation,2003,108(6):736-740.
  • 10Tanii M, Yonemitsu Y, Fujii T, et al. Diabetic microangiopathy in ischemic limb is a disease of disturbance of the platelet-defived growth factor-bb/protein kinase C axis but not of impaired expression of angiogenic factors. Circ Res, 2006,98:55-62.

共引文献38

同被引文献23

  • 1陈灏珠,林果为.实用内科学[M].北京:人民卫生出版社,2010:2389.
  • 2JANSSON P A. Endothelial dysfunction in insulin resist- ance and type 2 diabetes [ J ]. J Intern Med, 2007, 262 (2) : 178-183.
  • 3ARAKI A. Dementia and insulin resistance in patients with diabetes mellitus [ J]. Nippon Rinsho, 2010, 68 (3) : 569-574.
  • 4NAVANEETHAN S D, KELLY K R, SABBAGH F, et al. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery [J]. Obes Surg, 2010, 20 (3) : 308- 315.
  • 5WATANABE Y, FUJII H, AOKI K, et al. A cross sec- tional survey of chronic kidney disease and diabetic kid- ney disease in Japanese type 2 diabetic patients at four urban diabetes clinics [ J ]. Intern Med, 2009, 48 (6) : 411-414.
  • 6WALL B M, HARDISON R M, MOLITCH M E, et al. High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline data [ J ]. Am J Med Sci, 2010, 339 (5): 401-410.
  • 7KANG Y S, CHAD R. The role of visfatin in diabetic nephropathy [ J ] . Chonnam Med J, 2011, 47 ( 3 ) : 139-143.
  • 8陈新谦,金有豫,汤光.新编药物学[M]. 17版.北京:人民卫生出版社,2011:67 -68.
  • 92007年版中国2型糖尿病防治指南[J].中华内分泌代谢杂志,2008,24(2). 被引量:267
  • 10许雯,翁建平.新诊断2型糖尿病患者与胰岛素强化治疗[J].新医学,2008,39(7):425-428. 被引量:14

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部